Efficacy of adjuvant chemotherapy for patients with poor‐risk medulloblastoma: A preliminary report

Roger J. Packer(Children's Hospital of Philadelphia), Luis Schut(Children's Hospital of Philadelphia), Greta R. Bunin(Children's Hospital of Philadelphia), Lucy B. Rorke(Thomas Jefferson University), Leslie N. Sutton(California University of Pennsylvania), Audrey E. Evans(Purdue University West Lafayette), Giulio J. D’Angio(University of Pennsylvania), Kathy R. Siegel(Children's Hospital of Philadelphia)
Annals of Neurology
October 1, 1988
10.1002/ana.410240405
Cited by 87

Related Papers

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
|Journal of Clinical Oncology|1993|2.3k
A Randomized Trial of Prenatal versus Postnatal Repair of Myelomeningocele
|New England Journal of Medicine|2011|2.2k
A proposed staging for children with neuroblastoma.Children's cancer study group A
|Cancer|1971|953
Treatment of Wilms' tumor. Results of the third national Wilms' tumor study
|Cancer|1989|685
Risk stratification of childhood medulloblastoma in the molecular era: the current consensus
|Acta Neuropathologica|2016|650